CTRI Number |
CTRI/2025/04/085317 [Registered on: 22/04/2025] Trial Registered Prospectively |
Last Modified On: |
18/04/2025 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
Bruhatyadi Dhoopan and Neembadi Dhoopan Herbal Smoke Treatments to Reduce Pain After Surgery for Common Ano Rectal Problems |
Scientific Title of Study
|
Randomized Controlled Clinical Trial Of Bruhatyadi Dhoopan And Neembadi Dhoopan For The Management Of Post Operative Pain In Benign Anorectal Diseases |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Jigar Darji |
Designation |
PG Scholar |
Affiliation |
Parul University |
Address |
Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda
Vadodara GUJARAT 391760 India |
Phone |
6355536316 |
Fax |
|
Email |
jigardarji024@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Parikshit Shirode |
Designation |
Professor |
Affiliation |
Parul University |
Address |
Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda, Vadodra Gujrat
Vadodara GUJARAT 391760 India |
Phone |
9960063588 |
Fax |
|
Email |
parikshit.shirode260038@paruluniversity.ac.in |
|
Details of Contact Person Public Query
|
Name |
Dr Parikshit Shirode |
Designation |
Professor |
Affiliation |
Parul University |
Address |
Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda, Vadodra Gujrat
Vadodara GUJARAT 391760 India |
Phone |
9960063588 |
Fax |
|
Email |
parikshit.shirode260038@paruluniversity.ac.in |
|
Source of Monetary or Material Support
|
Parul Institute OF Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat India 391760 |
|
Primary Sponsor
|
Name |
Parul Institute Of Ayurved |
Address |
Parul Institute OF Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat India 391760 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Jigar Darji |
Parul Institute Of Ayurved |
Parul Institute of Ayurved Department of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat Vadodara GUJARAT |
6355536316
jigardarji024@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics committee Parul Institute Of Ayurved |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:K629||Disease of anus and rectum, unspecified. Ayurveda Condition: SULAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Bruhati , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (2) Medicine Name: Ashwagandha , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (3) Medicine Name: Pippali , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (4) Medicine Name: Tulsi , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Nimba, Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (2) Medicine Name: Gour Sarsha, Reference: Shusrut Samhita , Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (3) Medicine Name: Guggulu , Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan (4) Medicine Name: Vacha , Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan |
|
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1.Patients undergone anorectal surgeries and suffering from pain of intensity 7 to 10 on vas scale will be enrolled for Dhoopan procedure.
2.Patients wilfully giving well informed written consent.
3.Age group between- 20 years to 60 years.
|
|
ExclusionCriteria |
Details |
1.Patients with disorders like Malignancy, Syphilis, Tuberculosis, Leprosy
2. HIV+ve, HBsAg+ve, VDRL+ve,
3.Patient with uncontrolled diabetes mellitus and hypertension.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Post Operative Pain Reductions Without Use of Oral Pain Killers
|
from commencement of pain reduction in
between 1 hours, 6 hours ,12 hours ,24
hours postoperatively for 5 days post
operative days
|
|
Secondary Outcome
|
Outcome |
TimePoints |
No Gastric Acid Reflux Will Be Seen Due To intake No Need Of Painkiller In Post Operative Period |
from commencement of pain reduction in
between 1 hours, 6 hours ,12 hours ,24
hours postoperatively for 5 days post
operative days
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
09/05/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Ano-rectal conditions like hemorrhoids, fistula in ano, chronic fissure associated with
sentinel tag are common conditions requiring surgical excision followed by significant post
operative pain, making effective pain management crucial for patient recovery. Conventional pain medications may have side effects such as gastrointestinal issues and
dependency, necessitating safer, alternative treatments. Incorporating traditional medicine with modern post-surgical care could provide a more
comprehensive approach to pain management.Ayurvedic formulations like Bruhatyadi Dhoopan and Neembadi Dhoopan may offer natural and
holistic pain relief options without adverse effects, but clinical evidence is lacking.This study aims to evaluate the
clinical efficacy of Bruhatyadi Dhoopan and Neembadi Dhoopan for managment of post operative ano-rectal pain.The study will assess pain reduction (VAS scale), patient satisfaction, and adverse effects over seven days post-surgery. Hence the need and uniqueness of study. |